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COMPARISON OF REVISION RISKS AND COMPLICATION 
RATES BETWEEN TOTAL HIP REPLACEMENT AND HIP 
RESURFACING WITHIN THE SIMILAR AGE GROUP 
Abstract 
 
Background and Purpose: Currently it is not clear whether age is a factor affecting 
revisions in total hip replacement (THR) and hip resurfacing (HR). This study aimed to 
investigate which of THR or HR is a higher risk in terms of revision and complication 
within similar age groups.  
Methods: A systemic review was performed for published literature research databases 
and local data and compared the two procedures under the condition that both groups of 
patients were age matched. Meta-analysis techniques were used to analyse revision and 
complication rates. Twenty-seven literature studies were included along with local audit 
data. In total, 2520 HR procedures were compared with age-matched 2526 of THR 
procedures. 
Main findings: It was found that revision risk of HR is significantly higher than THR 
(risk ratio 1.65, 95% CI 1.28-2.31, p<0.0001), highlighting that HR has a slightly higher 
chance of reoperation when compared to THR within the similar age group population. 
In terms of complications, HR was found to have an advantage over THR (risk ratio 
0.84, 95% CI 0.73-0.96, p<0.01).  
Conclusion: THR had a lower revision risk but a slightly higher complication risk than 
HR under the condition that the two surgical procedures were applied to similar age 
groups of patients. In other words, age has not played an important role in revision and 
complication. Survivorship cannot be measured as follow-up periods were different in 
the studies used.  
 
Keywords: Total hip replacement, Hip resurfacing, Age, Revision, Risk ratio.  
Introduction 
Total hip replacement (THR) is the surgical procedure for treating end-stage arthritis of 
the hips and to enhance the quality of life in elderly patients, with a survivorship of 90% 
at 10 years.
1
 In young males under 55 years of age, survivorship reduces to 80% at 10 
years and may drop as low as 58% at 15 years.
2
 Thus, revision surgery becomes vital. 
Sometimes, depending on patient age, multiple revisions may be required.  
Hip resurfacing (HR) has now advanced as a substitute to THR and is thought to have 
the potential to resolve the issue of survivorship in young patients with a survivorship 
greater than 95% at five years and can increase to 98%.
2, 3 
The available literature is still 
inconsistent regarding rates of revision, incidences of complications, functional 
outcomes, patient satisfaction, and long-term results.
4, 5 
Despite numerous theoretical 
advantages over THR, HR has been associated with specific complications, for example, 
periprosthetic femoral neck fractures and metal particle issues, which has therefore 
caused surgeons confusion in regard to using it as the standard treatment method for 
younger patients.
6 
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Given that many believe that THR is suitable for the older age group whilst HR is better 
for the younger age group, the research question is whether age is a factor affecting 
revision and complication rates. In most studies, the patient data is divided for the two 
surgical procedures with different age, and the outcomes and therefore cannot be 
compared. Therefore, if the patients are matched for age, the efficacy of HR could then 
be appreciated. Although the literature studies have investigated these two surgical 
modalities and assessed the evidence base with respect to their clinical, functional and 
radiological results, there has been little formal meta-analysis regarding the revision and 
complication risk of HR and THR from the comparative studies. Very few studies have 
compared these two procedures performed simultaneously and there is no study which 
has compared them for similar age groups. 
To investigate whether the efficacy of one surgical procedure over the other, this current 
study employed meta-analysis to investigate the two procedures within similar age 
groups. To our best knowledge, such analysis has not been carried out before and will 
provide more accurate risk assessment of the procedures, and can compare HR and THR 
more comprehensively. 
 
Materials and Methods 
Search strategy. The primary search was done from the databases of the search 
engines, including PubMed Medline, ScienceDirect, Web of Science, Embase and 
Scopus. These were searched via Ovid using key terms “hip resurfacing compared to 
total hip replacement and/or arthroplasty”, “revision rates of hip resurfacing and total 
hip replacement”, “survivorship after hip resurfacing” and “results of hip resurfacing 
and total hip replacement”. A secondary search was done from the reference list of 
relevant articles. Two authors carried out the selection of available articles.  
 
Eligibility criteria. Using the obtained search results, relevant randomized controlled 
trials (RCTs) and observational studies (prospective and retrospective) were identified, 
which compared HR with THR. There was no language restriction in the search. There 
were no search specifications based on subject age, gender, preoperative diagnosis and 
type of prosthesis used. As the aim of the study was to look into specific factors like age 
group, the studies selected were where patient’s mean age difference between two 
modalities (HR and THR)  were 5 or <5 years. To avoid surgical and clinical bias, 
articles included were only those that compared the two surgical procedures in terms of 
revisions, complications, functional results and survivorship. Thus, inclusion criteria 
were as follows: HR and THR comparative studies, studies having patient’s mean age 
difference 5/<5 years between HR and THR groups, and both procedures performed 
after the year 1990. The following studies were excluded: animal and cadaver studies, 
case reports, studies that report comparison outcomes of revision procedures, retrieval 
studies for failed implants, studies that compared either HR or THR with results of joint 
registries, meta-analysis, systematic reviews or editorial papers and studies which had 
either procedure performed before the year 1990. In total, 27 studies fitted all criteria 
(Figure 1). 
 
[Figure 1] 
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Data extraction. Data were extracted from the included studies. The information 
collected was type of study (randomised, prospective or retrospective), patients' mean 
age, male and female ratio, average body mass index (BMI), number of patients in each 
cohort, time frame during which surgeries were performed, minimum follow-up, 
surgical approach used, type of prosthesis implanted, mean  preoperative and 
postoperative Harris Hip Score (HHS), number of surgeons involved, number of 
complications, number of revisions with their reasons, and the overall survival. Another 
set of data was extracted from the xxxx (TAAG) database that was age and gender 
matched with all the same details as the studies from the literature. The TAAG database 
includes HR and THR surgeries performed during 2000-2014. TAAG data was analysed 
as one of the data sources parallel with the literature studies. The appropriate Caldicott 
ethical approval was obtained from the local University and NHS. 
Primary outcome measure. The frequency of revision surgery due to any reason was 
the primary outcome measure.  
 
Secondary outcomes measures. Included frequency of complications and preoperative 
and postoperative Harris Hip Score (HHS). Other outcome measures such as approach, 
duration of surgery, the length of hospital stay, radiological outcomes, quality of 
outcomes and immediate postoperative recovery status were not considered. All the 
complications (irrespective of their nature and time of occurrence) were grouped 
together for the outcome analysis.  
 
Statistics. A meta-analysis was undertaken for the data extracted from the included 
studies and the local TAAG data. This was done using RevMan 5 software (version 
5.3.5 Java 7 version for Mac OS X; The Nordic Cochrane Centre, Copenhagen, 
Denmark). IBM statistical package for social sciences (SPSS version 22) software was 
used to analyse the local data from the TAAG. Statistical heterogeneity was assessed 
with Chi
2
 and I
2
 tests. To assess any publication bias for the outcome measures, funnel 
plots were generated using the software RevMan 5, for revisions as well as for 
complications. The results of a comparable group were pooled using both the fixed-
effect (Mantel-Haenszel test) and random-effect (DerSimonian and Laird method) 
models. Forest plots were created using the RevMan 5 software. A fixed-effect model 
was used for both the outcomes, as there was mild heterogeneity between studies for the 
outcomes of revision (I
2
=6%) and no heterogeneity between studies for the outcomes of 
complications (I
2
=0%). Mantel-Haenszel method was used to calculate risk ratio along 
with 95% confidence intervals (CI) for dichotomous data. For the outcomes, the current 
study used Risk Ratio (RR) as the summary static. RR was defined by the ratio of 
revision rates of HR to revision rates of THR. A revision rate was the ratio of the 
number of revision cases to the number of total cases. Similarly, the Risk Ratio for 
complications was the ratio of complication rates of HR to THR. In other words, if RR 
is larger than 1, HR has larger risk than THR, or vice versa. The p value <0.05 
anywhere was considered significant.  
 
Results 
Cohort characteristics. From the 27 citations, 11 randomized controlled trials, 7 
prospective and 9 retrospective studies were identified. The funnel plots revealed that no 
bias was present for the studies (Figures 2a and 2b). Altogether, there were 1862 HR 
procedures that were compared with 1899 THR procedures. From the local TAAG data, 
658 HR were compared with age-matched 658 THR. In the included studies,
7-33
 the 
mean age in the HR group was 51.3 years (SD 5.3) while the mean age in the THR 
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group was 52.8 years (SD 5.3). In the TAAG data, mean age was similar for the two 
groups 51.5 years (SD 8.3). In the included studies,
7-33
 there were 1305 males and 516 
females in the HR group. The THR group had 1240 males and 721 females. The TAAG 
data had 434 males and 224 females in the HR group, and 278 males and 380 females in 
the THR group. Twenty studies stated BMI, 
7-33
 for which means were 27.1 (SD, 1.4) 
and 28.1 (SD, 1.5) in HR and THR group respectively. Means of BMI in TAAG data 
were 27.8 (SD, 4.2) and 28.9 (SD, 5.8) for the HR and THR group respectively (Table 
1). The follow-up of various studies ranged from the minimum of 6 months to 
maximum of 120 months. The demographic characteristics of all the included studies 
are shown in Table 1 and Table 2. 
 
[Figures 2a and 2b] 
[Tables 1 and 2] 
 
Different types of prosthesis were used in the included studies.
7-33
 The most common 
systems used for HR were Durom hybrid resurfacing 
10-16
 followed by Conserve plus.
7, 9, 
20, 23, 26, 30
 For the THR group the variety of implants used are shown in Table 3. In the 
TAAG data, the most commonly used system for resurfacing was Birmingham Hip 
Resurfacing (BHR) in 96% of cases. The collared polished tapered (CPT) and Exeter 
prosthesis accounted for 43% of the THR implants used. The most common indication 
for surgery was osteoarthritis.  
 
[Table 3] 
 
Meta-analysis 
Risk Ratio for Revision rates. Of the included 27 literature studies, eight studies had 
zero revisions in both HR and THR groups. 
11, 13, 18-21, 23, 31
 Since there was marginal 
heterogeneity between studies for the outcome of revisions (I
2
=5%), the fixed–effect 
model was used for the analysis. The pooled data, i.e. 27 literature studies and TAAG, 
showed a higher incidence of revision in the HR group than in the THR group with 
significant difference (RR, 1.65; 95% CI, 1.28-2.31; p<0.0001) and total revisions 
reaching 142 in the HR group and 86 in the THR group out of 2520 and 2556 cases 
respectively as seen in Figure 3. Moreover, when a random-effect model was used, the 
results were almost the same as the fixed-effect model (RR, 1.63; 95% CI, 1.20-2.20; 
p<0.002), favoured THR (Figure 4). With both the models (fixed-effect and random-
effect), the overall effect remained significant (p<0.0001 and p<0.002) and the overall 
outcome favoured THR. 
 
[Figs 3-4] 
 
Risk Ratio for Complication rates. The complications were described in 22 literature 
studies and in the TAAG data. Five studies did not report complication rates.
13, 15-16, 23, 31 
As there was no heterogeneity between studies for the outcome of complications (I
2
=0), 
the fixed-effect model was used for the analysis. The overall complication risk in the 
literature studies and TAAG data was significant (RR, 0.84; 95% CI, 0.73-0.96; p<0.01) 
as seen in Figure 5. The causes of revisions for both HR and THR are described in Table 
4 and Figure 6. The study by Stulberg et al (2009) had the maximum weight (34.9%), 
followed by local TAAG data (34.3%).
22
 As the complication information was not fully 
reported by the literature studies, we report the complication details from TAAG only 
for reference. In the TAAG data, there were 86 complications for HR and 112 
5 
 
complications for THR (Table 5 and Figure 7). Other complications were systemic such 
as anaemia, pyrexia, postoperative hypotension, pressure sores etc. (encountered in both 
groups). It is not clear whether these complications were responsible for the revisions.     
 
[Tables 4-5] 
[Figures 5-7] 
Discussion 
The main findings of this study are that HR has a higher risk of revision when compared 
to THR (p<0.001) within the similar age groups. Regarding complications, HR had a 
lower ratio than THR (p<0.01). High rates of revision in HR could be related to many 
factors such as surgeon’s experience, inappropriate patient and implant selection, but 
not to age. Currently, there is a lack of availability of long-term data on the modern HR 
designs. Still there is a lack of evidence to prove the clinical and functional superiority 
of HR over THR, but HR can provide similar functional results to THR, under 
experienced surgeon in a carefully selected patient in terms of age, gender and 
prosthesis design. 
Revision rates described in early studies were poor with HR and related to factors such 
as early wear, osteolysis, and component loosening.
34
  Whereas in another meta-analysis 
by Smith et al, HR had twice the revision risk as compared to THR.
35
 A systemic review 
by Deborah et al 
36
 showed that revision rates are more frequent and early in HR when 
compared to THR. In all these studies, age has not been considered as a specific factor. 
Of the 27 included studies, five studies projected higher revisions risk in THR group as 
compared to HR group, 
9, 16, 28-29, 32
 eight studies could not estimate revision risks as 
there were no revisions in each group and 11 studies favoured THR by showing higher 
revision risk in HR. Three studies 
7, 30, 33
 showed exact equal revision rates with both 
procedures. Therefore, the current study, based on available literature and local data, 
provides relatively reliable evidence that HR is higher in revision than THR within 
similar age groups.  
The current study also indicated that there may be an association between the type of 
prosthesis used and revision rates in the HR group. Seven of the included studies 
10-16
 
used the Durom system, of which four had higher revisions for HR,
10, 12, 14-15
 one study 
showed THR with higher risk 
16
 and the other two studies could not estimate the 
revision risk 
11, 13
. Although the contributors to the failure of HR are multifactorial, 
component design, geometry, and acetabular component orientation could be the most 
important factors.  
The current study also demonstrated that the complication risk in HR was better than 
THR (p<0.01). Nearly half of the described studies had high proportions of 
complications for THR as compared to HR. However, it was unclear what proportion of 
these complications were converted into revisions. Some of the complications, such as 
acute dislocation, sciatic nerve palsy, squeaking and trochanteric bursitis, were treated 
by re-operations rather than revising the existing components. Re-operations are a 
different entity from revisions and it was not known what proportion of these 
complications were actually revised or re-operated. In the TAAG data, the most 
common complications included infection (both deep and superficial), aseptic loosening 
and metallosis, accounting for approximately 75% of all complications. The revisions 
due to these three complications comprised approximately 70% of all the revisions. In 
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the THR group, common complications were infections (deep and superficial), 
periprosthetic fractures and aseptic loosening, which accounted for approximately 57% 
of all the complications and these were responsible for approximately 71% of the total 
revisions in the THR group. Marshall et al 
37
 concluded that revisions and reoperations 
were more frequent and occurred earlier with HR except when discontinued devices 
were removed from the analysis. Conversely, dislocations were more frequent with 
THR. 
 
Strength and weaknesses. The strength of the current study is that it considered those 
comparative studies which had these procedures with similar mean age group, thereby 
minimising the surgical bias, which is the important key factor for the outcome of these 
procedures. Secondly, as HR had earlier poor results and unacceptably high rates of 
failures, it was taken into account only those studies that had these surgeries performed 
after the year 1990 when modern HR designs were first used. The strict selection criteria 
make this study unique. The study had a few limitations. Firstly, the included studies 
had inadequate length of follow-up, which are deficient in long-term follow-up data for 
modern HR when compared to conventional THR procedures. So, therefore no 
survivorship analysis was possible. Secondly, the included studies were not implant 
(prosthesis) specific. Thirdly, there could be a bias in revision risk, and it was not clear 
from available data what ratio of complications were converted to revisions. Finally, 
some of the included studies were operated by multi-level surgeons, which could affect 
the final outcome. 
 
From the current study, it is still unclear regarding the superiority of one procedure over 
another. We can undoubtedly state that there is still argument and scope for further 
research on this topic. We need to review more isolated long-term randomized, 
prospective trials that will have a high level of evidence to the final outcome of the 
research. Moreover, research should also focus on other aspects such as surgical 
techniques, specific implant designs, and metallurgy.  
Conclusion 
The findings of the current study indicate that the revision risk of HR is significantly 
higher than THR within similar age group population. Literature studies have not 
reported this conclusion using age-matched data. In terms of complications, HR is found 
to have the advantage in comparison with THR. Survivorship cannot be measured as the 
follow-up periods were different in the studies used.
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Figure captions 
Figure 1. Preferred reporting items for systematic reviews and meta-analysis (PRISMA) 
flow chart. 
Figure 2. Funnel plots showing rare publication bias for a frequency of revision surgery on 
the left (2.a) and no publication bias for a frequency of complications on the right (2.b). 
Note: Each dot represents a study/data source used; the vertical-axis shows study 
precision and the horizontal-axis gives the study's result. A symmetric inverted funnel 
shape means a ‘good-quality’ data set, in which publication bias is unlikely.   
 
Figure 3. Forest plot to illustrate the difference in frequency of revision surgery between 
HR and THR using fixed-effect model. 
Note: Forest plot shows risk ratios for each study (the point being the value and the line 
being associated confidence intervals), and the vertical line represents no effect. As risk 
ratio is calculated by HR/THR, and thus a value > 1 means that HR has higher risk than 
THR in revision. 
Figure 4. Forest plot to illustrate the difference in frequency of revision surgery between 
HR and THR using random-effect model. 
Note: The random-effect model is used to analyse data with bias. We use this model to 
double check the results from Figure 3 where a fixed-effect model was used. The results 
shows that both models gave similar results. 
Figure 5. Forest plot to illustrate the difference in frequency of complications between HR 
and THR. 
Note: As risk ratio is calculated by HR/THR, and thus a value > 1 means that HR has 
higher risk than THR in complication. 
Figure 6. Proportion of complications in HR and THR in TAAG data. 
Note: The results are displayed as clinical reference rather than statistical comparison   
 
Figure 7. The reasons for revisions in HR and THR in both Literature studies and TAAG 
data. 
Note: The results are displayed as clinical reference rather than statistical comparison   
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Table 1. Demographic characteristics of the Literature studies and TAAG data 
Characteristics 
Literature Studies TAAG Data 
HR Studies 
 
THR Studies 
 
HR THR 
No. of studies 27 27   
Total No. of hips 1862 1899 658 658 
Gender M/F 1305/516 1240/721 434/224 278/380 
Mean age, yrs (SD; range) 51.3 
(5.3;34-64) 
52.8 
(5.3;35-64) 
51.5 
(8.3;21-75) 
51.5 
(8.3;21-75) 
Mean BMI (kg/m
2
) (SD; range) 27.1 
(1.4;23.5-29) 
28.1 
(1.5;23.3-30) 
27.8 
(4.2;12.8-42.1) 
28.9 
(5.8;11.1-64.9) 
Mean pre-op HHS, months 
(SD) 
50.0 
(6.85) 
47.7 
(6.37) 
48.9 
(11.5) 
43.6 
(10.9) 
Mean post-op HHS, months 
(SD) 
93.0 
(3.89) 
92.80 
(4.5) 
94.5 
(9.8) 
87.7 
(11.4) 
Diagnosis 
 Osteoarthritis 
 Dysplastic Hip 
 Osteonecrosis 
 Post-traumatic arthritis 
 Ankylosing Spondylitis 
 Perthes’ Disease 
 Rheumatoid Arthritis 
 Others 
 Not recorded 
 
1333 
90 
119 
19 
0 
0 
19 
0 
282 
 
1256 
80 
128 
20 
0 
0 
20 
0 
395 
 
575 
38 
12 
7 
6 
5 
1 
14 
0 
 
501 
21 
54 
6 
6 
15 
24 
32 
0 
Surgical approach 
 Posterior 
 Anterolateral 
 Lateral 
 Posterolateral 
 Not recorded 
 
1151 (16) 
237 (4) 
0 
76 (2) 
398 (5) 
 
888(15) 
237 (4) 
0 
176 (3) 
598 (5) 
 
636 
12 
9 
0 
1 
 
206 
395 
27 
29 
1 
No. of complications 198 203 86 112 
No. of revisions 77 45 65 41 
Note: SD: standard deviation; HHS; Harris Hip Score; TAAG is local data used as one of data sources in 
meta-analysis. 
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Table 2. Demographic characteristics of the Randomized controlled trials and selected data 
sources 
 
Randomized 
controlled 
trials 
No. of hips 
Males / 
Females 
Mean 
age 
(years) 
Mean BMI 
(kg/m
2
) 
Duration of 
Surgeries 
Min. 
follow-up 
(months) 
Bisseling et al
7
  
HR-38 21/17 57.5 26.1 2007-2010 36 
THR-33 21/12 59.2 28 2007-2010 36 
Gustafson et al
8
  
HR-19 9/10 64 26 2005-2007 60 
THR-25 7/18 64 27 2005-2007 60 
Smolders et al
9
  
HR-38 21/17 57.5 26.1 2007-2010 24 
THR-34 21/13 59.1 28 2007-2010 24 
Vendittoli et al
10
  
HR-109 69/40 49.2 27 2003-2006 96 
THR-100 68/32 51 30 2003-2006 96 
Lavigne et al
11
  
HR-24 14/10 49.6 27.9 2006-2007 12 
THR-24 15/9 49.8 27.8 2006-2007 12 
Vendittoli et al
12
  
HR-64 42/22 49 27.1 2003-2006 24 
THR-53 33/20 51 29.2 2003-2006 24 
Garbuz et al 
13
 
HR-48 45/3 51.5 28.3 2005-2008 12 
THR-56 50/6 52 28.2 2005-2008 12 
Rama et al
14
 
HR-56 65/38 50 27.3 2003-2005 12 
THR-97 66/31 50 29.7 2003-2005 12 
Lavigne et al
15
  
HR-81 53/28 48.4 27 - 27 
THR-71 51/20 50 28.7 - 27 
Girard et al
16
  
HR-49 31/18 47 27.3 2003-2005 12 
THR-55 34/21 48 29.6 2003-2005 12 
Howie et al
17
  
HR-11 6/5 46 - 1993-1995 101 
THR-13 9/4 50 - 1993-1995 101 
Prospective studies 
Fink Barnes et 
al
18 
HR-89 80/0 52.7 28.6 2006-2010 24 
THR-47 43/0 57.4 30.3 2006-2010 24 
Costa ML et al
19
  HR-60 38/22 56.3 28.6 2007-2010 12 
THR-66 36/30 56.6 28.7 2007-2010 12 
Wang et al
20
  HR-37 5/29 45.7 23.5 2005-2006 59.4 
THR-39 9/29 46.5 23.3 2005-2006 60.6 
Sandiford et al
21
  HR-141 93/44 55.3 26 2000-2002 19.2 
THR-141 75/59 53.9 26 2000-2002 13.4 
Stulberg et al
22
  HR-337 228/109 50 - 2001-2003 24 
THR-266 165/101 53 - 2001-2003 24 
Zywiel et al 
23
 HR-33 23/10 53 28 2002-2005 42 
THR-33 23/10 53 29 2002-2005 42 
Mont et al
24
  HR-30 18/12 34 - 1992-1996 84 
THR-30 18/12 35 - 1992-1996 90 
Retrospective studies 
Parry et al
25
 HR-87 79/8 53 - 2004-2010 72 
THR-89 34/55 58 - 2004-2010 60 
Arndt et al
26
 HR-55 38/17 49.6 - 2002-2005 48.6 
THR-100 74/26 56.5 - 1997-2001 56.8 
Issa et al
27
  HR-120 114/0 50 28.2 2007-2009 40 
THR-120 117/0 53 28.7 2007-2009 40 
Costa CR et al
28
  HR-73 63/4 51 28 2007-2009 30 
THR-137 65/60 54 28 2007-2009 30 
Baker et al
29
  HR-63 40/11 49.8 25.7 1999-2001 108 
THR-54 40/13 50.4 27 1996-2001 108 
Mont et al
30
  HR-54 36/18 55 29 2002-2005 39 
THR-54 36/18 55 29 2002-2005 39 
Patel et al
31
  HR-12 9/3 55.9 - - 24 
THR-12 9/3  57.8 - - 24 
Hall et al
32
  HR-33 27/6 53.7 - 2006-2007 6 
THR-99 81/18 55.3 - 2006-2007 6 
Pollard et al
33
  HR-54 40/13 50 25.7 1999-2001 61 
THR-51 40/11 50 27 1996-2001 80 
TAAG data HR-658 434/224 51.5 27.8 2001-2011 120 
THR-658 278/380 51.5 28.9 2001-2011 120 
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Note: Selected studies have similar age groups in THR and HR; Follow-up are different. 
Table 3. Varieties of prosthesis used in HR and THR in literature studies and local data 
HR prosthesis type 
No. of patients (No. of 
literature studies) 
using the implant 
(n=1862) 
No. of patients using 
the implant in TAAG 
data (n=658) 
Birmingham Hip Resurfacing system (Smith and 
Nephew, Warwick UK) 
380 (4) - 
BHR-Midland Technologies, UK 66 (2) 622 
Conserve Plus (Wright Medical Technology, 
Arlington, TN) 
255 (6) - 
Durom hybrid resurfacing system 
(Zimmer, Warsaw, IN) 
478 (7) 34 
Cormet MoM (Corin, UK) 530 (3) - 
Stemless resurfacing system 
(Depuy, Warsaw, IND) 
30 (1) - 
McMinn acetabular and mini stemmed McMinn 
femoral resurfacing component (Corin Medical 
Ltd, UK) 
11 (1) - 
Recap Femoral Resurfacing System 
(Biomet,UK) 
19 (1) - 
Mitch TRH (Stryker)                                        0 (0) 2 
Not stated 93(2) - 
 
THR prosthesis type 
No. of patients (No. of 
literature studies) 
using the implant  
No. of patients using 
the implant in TAAG 
data 
Zweymuller Classic (Zimmer) 67(2) - 
CLS Spotorno (Zimmer) 232(3) 54 
CPT (Zimmer) 145(3) 188 
VERSYS FMT (Zimmer) 100(1) - 
M/L Taper (ZIMMER) 56(1) 31 
Exeter (Howmedica, Stryker) 92(3) 92 
E-series (Stryker) 90(1) - 
Accolade (Stryker) 290(3) 10 
SL Plus (Stryker)  39(1) - 
ABG I and II (Stryker) 266(3) 15 
Aesculap (Aesculap) - 17 
Biomet (Biomet) - 1 
Summit and Pinnacle (Depuy) 89(1) - 
Corail pinnacle (Depuy) 141(1) 1 
Charnley (Depuy) - 51 
Lubinus (LINK) - 23 
Mayo (Zimmer) - 64 
Polarstem (Smith and Nephew) - 1 
Profemur (Wright Medial) - 1 
S-ROM (Depuy) - 1 
Spectron (Smith and Nephew) 12(1) 3 
Synergy (Smith and Nephew) - 96 
Taperloc (Biomet) - 6 
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Table 4. Reasons for revision in HR and THR in both Literature studies and TAAG data 
Reason for Revision 
No of revisions in Literature 
studies 
(% of total revisions) 
No revisions in TAAG data 
(% of total revisions) 
HR THR HR THR 
Aseptic loosening of acetabulum/ 
femur 
39 (50.6%) 15 (33.3%) 22 (33.8%) 8 (19.5%) 
Infection 3 (3.9%) 8 (17.7%) 4 (6.1%) 4 (9.7%) 
Peri-prosthetic fracture 19 (24.6%) 8 (17.7%) 5 (7.6%) 5 (12.2%) 
Dislocation 3 (3.9%) 12 (26.6%) 3 (4.6%) 8 (19.5%) 
Unexplained pain 3 (3.9%) 2 (4.4%) 11 (16.9%) 6 (14.6%) 
Metallosis 6 (7.7%) - 18 (27.6%) 10 (24.3%) 
Avascular necrosis of femoral head 4 (5.1%) - 2 (3%) - 
Total Revisions 77 45 65 41 
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Table 5. Common complications in the two groups of TAAG data 
Complication No of HR cases No of THR cases 
Superficial infection 13 21 
Deep infection 5 17 
Loose acetabulum/ femur 16 8 
Peri-prosthetic fracture 5 18 
Dislocation 4 13 
Deep Vein Thrombus (DVT) 2 4 
Metallosis 17 6 
Sciatic Nerve palsy 3 5 
Others (pyrexia, UTI, chest infections etc.,) 21 20 
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